01804nas a2200817   4500000000100000008004100001100001400042700001400056700001400070700001400084700001500098700001400113700001400127700001200141700001200153700000900165700001100174700001300185700001600198700001100214700001700225700001200242700001200254700001400266700001400280700001600294700001400310700001400324700001100338700001100349700001300360700001200373700001100385700001200396700002200408700001700430700002300447700001100470700001400481700001100495700001200506700002000518700001200538700001200550700001300562700001300575700001500588700001200603700001300615700001300628700001300641700001400654700001300668700001500681700001300696700001500709700001100724700001200735700001400747700001200761700002200773700001500795700001300810700001300823700001300836700001100849700001100860245009400871300001400965490000700979       2019                            d1 aSleight P1 aGrobbee D1 aBaigent C1 aBaigent C1 aEmberson J1 aWheeler D1 aKasiske B1 aKrane V1 aLevin A1 aDe Z1 aCass A1 aWanner C1 aSchlackow I1 aGray A1 aHerrington W1 aReith C1 aReith C1 aLandray M1 aLandray M1 aMihaylova B1 aCollins R1 aCollins R1 aBray C1 aChen Y1 aBaxter A1 aYoung A1 aHill M1 aKnott C1 aFeldt-Rasmussen B1 aFellström B1 aGrönhagen-Riska C1 aHaas M1 aHoldaas H1 aHooi L1 aJiang L1 aKrairittichai U1 aMassy Z1 aTesar V1 aWalker R1 aWiecek A1 aDasgupta T1 aLewis D1 aMafham M1 aMajoni W1 aParish S1 aSimpson D1 aStrony J1 aMusliner T1 aAgodoa L1 aArmitage J1 aChen Z1 aCraig J1 aGaziano J1 aGrimm R1 aOphascharoensuk V1 aPedersen T1 aTobert J1 aTomson C1 aHaynes R1 aKent S1 aNeal B00aCost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease  a170 - 1790 v96